Figure 3.

Percentage of patients with putative protective antibody levels (≥1 mg/L) for serotype 23 F 6B and both 23 F and 6 B (C) at vaccination, at 4 to 6 weeks after vaccination, and at 1.5-year follow-up in patients with rheumatoid arthritis (RA) and spondyloarthropathy (SpA) treated with different antiinflammatory drugs.

Crnkic Kapetanovic et al. Arthritis Research & Therapy 2013 15:R1   doi:10.1186/ar4127
Download authors' original image